Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Abstract Background Polypharmacy is associated with poorer health outcomes in older adults. Other than the associated multimorbidity, factors contributing to this association could include medication adverse effects and interactions, difficulties in managing complicated medication regimes, and reduc...

Повний опис

Бібліографічні деталі

Автори:	Dee Mangin, Larkin Lamarche, Gina Agarwal, Abbas Ali, Alan Cassels, Kiska Colwill, Lisa Dolovich, Naomi Dore Brown, Barbara Farrell, Karla Freeman, Kristina Frizzle, Scott R. Garrison, James Gillett, Anne Holbrook, Jane Jurcic-Vrataric, James McCormack, Jenna Parascandalo, Julie Richardson, Cathy Risdon, Diana Sherifali, Henry Siu, Sayem Borhan, Jeffery A. Templeton, Lehana Thabane, Johanna Trimble
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2023-05-01
Серія:	Pilot and Feasibility Studies
Предмети:	Polypharmacy Deprescribing Multi-morbidity Patient safety Primary care
Онлайн доступ:	https://doi.org/10.1186/s40814-023-01315-0
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!